Literature DB >> 11809429

Comparison of contrast echocardiography versus cardiac catheterization for detection of pulmonary arteriovenous malformations.

Jeffrey A Feinstein1, Phillip Moore, David N Rosenthal, Michael Puchalski, Michael M Brook.   

Abstract

Because clinical diagnosis of pulmonary arteriovenous malformations (AVMs) is difficult and cardiac catheterization invasive, contrast echo has been used to aid in the diagnosis. Correlation between contrast echo and catheterization data in these patients remains poorly defined. We examined the ability to detect pulmonary AVMs by contrast echocardiography, pulmonary angiography, and pulmonary vein saturations in patients who have undergone cavopulmonary (Glenn) shunts. Pulmonary vein saturations were obtained from catheterization reports. Blinded observers reviewed angiographic and contrast echo data retrospectively in 27 patients who had undergone a Glenn shunt and in 19 controls with biventricular hearts. Contrast echo was positive in 68 of 99 lungs (69%). Angiography showed AVMs in 65 of 98 lungs (66%). Pulmonary vein desaturation was found in 13 of 45 lungs sampled (29%). Only 10 of 38 lungs with positive contrast echo had pulmonary vein desaturation, but only 1 patient had pulmonary vein desaturation without positive contrast echo. The degree of desaturation did not correlate with severity of contrast echo return; 6 of 11 patients with 3+ contrast echo studies had normal pulmonary vein saturations. In a control group of patients with biventricular hearts, only 1 of 19 (5.3%) contrast echos was weakly positive. Contrast echo correlates poorly with angiography and pulmonary vein saturation for evaluation of AVMs. Contrast echo is extremely sensitive and often positive despite normal pulmonary vein saturation. Assessment of pulmonary vein desaturation in 100% oxygen may improve its sensitivity and correlation with contrast echo. Additional studies are needed to follow patients with mildly positive contrast echo studies to enable determination of their clinical relevance.

Entities:  

Mesh:

Year:  2002        PMID: 11809429     DOI: 10.1016/s0002-9149(01)02228-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

2.  Pulmonary arteriovenous malformations after cavopulmonary anastomosis.

Authors:  Anil Kumar Singhi; R Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2009-07

Review 3.  Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia.

Authors:  M Memeo; A Scardapane; R De Blasi; C Sabbà; A Carella; G Angelelli
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

Review 4.  Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

Authors:  M E Begbie; G M F Wallace; C L Shovlin
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 5.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

Review 6.  Pulmonary Vascular Sequelae of Palliated Single Ventricle Circulation: Arteriovenous Malformations and Aortopulmonary Collaterals.

Authors:  Andrew D Spearman; Salil Ginde
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-17

7.  Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets.

Authors:  Claire L Shovlin; Basel Chamali; Vatshalan Santhirapala; John A Livesey; Gillian Angus; Richard Manning; Michael A Laffan; John Meek; Hannah C Tighe; James E Jackson
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.